ID

29028

Description

Safety Study of BMS-816336 in Healthy Male Subjects; ODM derived from: https://clinicaltrials.gov/show/NCT00979368

Link

https://clinicaltrials.gov/show/NCT00979368

Keywords

  1. 2/21/18 2/21/18 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

February 21, 2018

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Diabetes Mellitus, Non-Insulin-Dependent NCT00979368

Eligibility Diabetes Mellitus, Non-Insulin-Dependent NCT00979368

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
healthy male subjects
Description

Healthy subject | Gender

Data type

boolean

Alias
UMLS CUI [1]
C1708335
UMLS CUI [2]
C0079399
bmi of 18 to 32 kg/m²
Description

Body mass index

Data type

boolean

Alias
UMLS CUI [1]
C1305855
men only, ages 18-55 years
Description

Gender | Age

Data type

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0001779
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
sexually active men not using effective birth control if their partners are wocbp
Description

Gender Sexually active | Contraceptive methods Lacking | Partner Childbearing Potential

Data type

boolean

Alias
UMLS CUI [1,1]
C0079399
UMLS CUI [1,2]
C0241028
UMLS CUI [2,1]
C0700589
UMLS CUI [2,2]
C0332268
UMLS CUI [3,1]
C0682323
UMLS CUI [3,2]
C3831118
any significant acute or chronic medical illness
Description

Illness | Chronic disease

Data type

boolean

Alias
UMLS CUI [1]
C0221423
UMLS CUI [2]
C0008679
family history of gilbert's disease
Description

Family history Gilbert Disease

Data type

boolean

Alias
UMLS CUI [1,1]
C0241889
UMLS CUI [1,2]
C0017551
history of pancreatitis
Description

Pancreatitis

Data type

boolean

Alias
UMLS CUI [1]
C0030305
evidence of organ dysfunction or any clinically significant deviation from normal in physical examination, vital signs, egg or clinical laboratory determinations
Description

Organ dysfunction | Abnormality Physical Examination | Abnormal vital signs | Electrocardiogram abnormal | Laboratory test result abnormal

Data type

boolean

Alias
UMLS CUI [1]
C0349410
UMLS CUI [2,1]
C1704258
UMLS CUI [2,2]
C0031809
UMLS CUI [3]
C0277804
UMLS CUI [4]
C0522055
UMLS CUI [5]
C0438215
qtc interval > 450 msec (corrected for heart rate using fridericia's correction method, qtcf)
Description

QTc interval QTcF - Fridericia's Correction Formula

Data type

boolean

Alias
UMLS CUI [1,1]
C0489625
UMLS CUI [1,2]
C1882513
second- or third-degree a-v block or clinically relevant ecg abnormalities
Description

Second degree atrioventricular block | Complete atrioventricular block | Electrocardiogram abnormal

Data type

boolean

Alias
UMLS CUI [1]
C0264906
UMLS CUI [2]
C0151517
UMLS CUI [3]
C0522055
history of allergy to 11-β-hsd-1 inhibitors or related compounds
Description

Hypersensitivity 11-beta-Hydroxysteroid Dehydrogenase inhibitors | Hypersensitivity Compound Related

Data type

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0044707
UMLS CUI [1,3]
C0243077
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C1706082
UMLS CUI [2,3]
C0439849
prior exposure to bms-816336
Description

Exposure to Substance Specified

Data type

boolean

Alias
UMLS CUI [1,1]
C0332157
UMLS CUI [1,2]
C0439861
UMLS CUI [1,3]
C0205369
use of st. john's wort (hypericum) within 4 weeks prior to the first dose of study drug and throughout the study
Description

Hypericum perforatum

Data type

boolean

Alias
UMLS CUI [1]
C0936242
use of an oral, injectable, inhalable or suspension of glucocorticoid agents within 12 weeks of study drug administration
Description

Glucocorticoids Oral | Glucocorticoids Injectable | Glucocorticoids Inhalant | Glucocorticoids Suspension

Data type

boolean

Alias
UMLS CUI [1,1]
C0017710
UMLS CUI [1,2]
C1527415
UMLS CUI [2,1]
C0017710
UMLS CUI [2,2]
C0086466
UMLS CUI [3,1]
C0017710
UMLS CUI [3,2]
C0001559
UMLS CUI [4,1]
C0017710
UMLS CUI [4,2]
C0038960
use of any glucocorticoid topical creams within 4 weeks of study drug administration
Description

Glucocorticoid Topical Cream

Data type

boolean

Alias
UMLS CUI [1,1]
C0017710
UMLS CUI [1,2]
C0991551
use of oral, injectable, or topical androgen agent within 12 weeks prior to enrollment
Description

Androgen Oral | Androgen Injectable | Androgen Topical

Data type

boolean

Alias
UMLS CUI [1,1]
C3536949
UMLS CUI [1,2]
C1527415
UMLS CUI [2,1]
C3536949
UMLS CUI [2,2]
C0086466
UMLS CUI [3,1]
C3536949
UMLS CUI [3,2]
C1522168

Similar models

Eligibility Diabetes Mellitus, Non-Insulin-Dependent NCT00979368

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Healthy subject | Gender
Item
healthy male subjects
boolean
C1708335 (UMLS CUI [1])
C0079399 (UMLS CUI [2])
Body mass index
Item
bmi of 18 to 32 kg/m²
boolean
C1305855 (UMLS CUI [1])
Gender | Age
Item
men only, ages 18-55 years
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Gender Sexually active | Contraceptive methods Lacking | Partner Childbearing Potential
Item
sexually active men not using effective birth control if their partners are wocbp
boolean
C0079399 (UMLS CUI [1,1])
C0241028 (UMLS CUI [1,2])
C0700589 (UMLS CUI [2,1])
C0332268 (UMLS CUI [2,2])
C0682323 (UMLS CUI [3,1])
C3831118 (UMLS CUI [3,2])
Illness | Chronic disease
Item
any significant acute or chronic medical illness
boolean
C0221423 (UMLS CUI [1])
C0008679 (UMLS CUI [2])
Family history Gilbert Disease
Item
family history of gilbert's disease
boolean
C0241889 (UMLS CUI [1,1])
C0017551 (UMLS CUI [1,2])
Pancreatitis
Item
history of pancreatitis
boolean
C0030305 (UMLS CUI [1])
Organ dysfunction | Abnormality Physical Examination | Abnormal vital signs | Electrocardiogram abnormal | Laboratory test result abnormal
Item
evidence of organ dysfunction or any clinically significant deviation from normal in physical examination, vital signs, egg or clinical laboratory determinations
boolean
C0349410 (UMLS CUI [1])
C1704258 (UMLS CUI [2,1])
C0031809 (UMLS CUI [2,2])
C0277804 (UMLS CUI [3])
C0522055 (UMLS CUI [4])
C0438215 (UMLS CUI [5])
QTc interval QTcF - Fridericia's Correction Formula
Item
qtc interval > 450 msec (corrected for heart rate using fridericia's correction method, qtcf)
boolean
C0489625 (UMLS CUI [1,1])
C1882513 (UMLS CUI [1,2])
Second degree atrioventricular block | Complete atrioventricular block | Electrocardiogram abnormal
Item
second- or third-degree a-v block or clinically relevant ecg abnormalities
boolean
C0264906 (UMLS CUI [1])
C0151517 (UMLS CUI [2])
C0522055 (UMLS CUI [3])
Hypersensitivity 11-beta-Hydroxysteroid Dehydrogenase inhibitors | Hypersensitivity Compound Related
Item
history of allergy to 11-β-hsd-1 inhibitors or related compounds
boolean
C0020517 (UMLS CUI [1,1])
C0044707 (UMLS CUI [1,2])
C0243077 (UMLS CUI [1,3])
C0020517 (UMLS CUI [2,1])
C1706082 (UMLS CUI [2,2])
C0439849 (UMLS CUI [2,3])
Exposure to Substance Specified
Item
prior exposure to bms-816336
boolean
C0332157 (UMLS CUI [1,1])
C0439861 (UMLS CUI [1,2])
C0205369 (UMLS CUI [1,3])
Hypericum perforatum
Item
use of st. john's wort (hypericum) within 4 weeks prior to the first dose of study drug and throughout the study
boolean
C0936242 (UMLS CUI [1])
Glucocorticoids Oral | Glucocorticoids Injectable | Glucocorticoids Inhalant | Glucocorticoids Suspension
Item
use of an oral, injectable, inhalable or suspension of glucocorticoid agents within 12 weeks of study drug administration
boolean
C0017710 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
C0017710 (UMLS CUI [2,1])
C0086466 (UMLS CUI [2,2])
C0017710 (UMLS CUI [3,1])
C0001559 (UMLS CUI [3,2])
C0017710 (UMLS CUI [4,1])
C0038960 (UMLS CUI [4,2])
Glucocorticoid Topical Cream
Item
use of any glucocorticoid topical creams within 4 weeks of study drug administration
boolean
C0017710 (UMLS CUI [1,1])
C0991551 (UMLS CUI [1,2])
Androgen Oral | Androgen Injectable | Androgen Topical
Item
use of oral, injectable, or topical androgen agent within 12 weeks prior to enrollment
boolean
C3536949 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
C3536949 (UMLS CUI [2,1])
C0086466 (UMLS CUI [2,2])
C3536949 (UMLS CUI [3,1])
C1522168 (UMLS CUI [3,2])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial